Details for: CUL2
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 9.02rCSI 25.36%PRS 69.36
-
CSI 8.63rCSI 13.15%PRS 70.67
-
CSI 4.78rCSI 12.36%PRS 69.02
-
CSI 4.75rCSI 3.59%PRS 86.75
-
CSI 4.29rCSI 3.26%PRS 86.7
-
CSI 4.21rCSI 3.02%PRS 87.16
-
CSI 4.02rCSI 9.57%PRS 74.15
-
CSI 3.86rCSI 6.22%PRS 63.56
-
CSI 3.8rCSI 2.56%PRS 87.21
-
CSI 3.67rCSI 4.99%PRS 83.68
-
CSI 3.65rCSI 9.52%PRS 74.45
-
CSI 3.59rCSI 8.05%PRS 56
-
CSI 3.55rCSI 7.92%PRS 81.79
-
CSI 3.51rCSI 5.78%PRS 78.86
-
CSI 3.43rCSI 21.43%PRS 65.48
-
CSI 3.38rCSI 11.32%PRS 58.1
-
CSI 3.21rCSI 6.52%PRS 52.15
-
CSI 3.17rCSI 7.24%PRS 65.2
-
CSI 3.14rCSI 3.76%PRS 72.11
-
CSI 3.1rCSI 3.05%PRS 88.11
-
CSI 3.1rCSI 2.3%PRS 66.99
-
CSI 3.06rCSI 2.3%PRS 80.03
-
CSI 3.02rCSI 2.5%PRS 76.5
-
CSI 3.01rCSI 3.48%PRS 65.51
-
CSI 2.89rCSI 2.28%PRS 61.64
-
CSI 2.85rCSI 1.99%PRS 88.28
-
CSI 2.68rCSI 4.87%PRS 64.93
-
CSI 2.63rCSI 1.55%PRS 89.73
-
CSI 2.61rCSI 3.74%PRS 63.48
-
CSI 2.52rCSI 2.64%PRS 77.28
-
CSI 2.48rCSI 1.73%PRS 77.32
-
CSI 2.42rCSI 3.96%PRS 63.19
-
CSI 2.38rCSI 3.82%PRS 57.12
-
CSI 2.32rCSI 3.04%PRS 85.83
-
CSI 2.29rCSI 4.6%PRS 63.53
-
CSI 2.28rCSI 8.19%PRS 53.53
-
CSI 2.25rCSI 5.2%PRS 61.96
-
CSI 2.18rCSI 3.76%PRS 64.83
-
CSI 2.15rCSI 3.05%PRS 70.33
-
CSI 2.15rCSI 2%PRS 74.74
-
CSI 2.14rCSI 3.14%PRS 66.77
-
CSI 2.11rCSI 2.26%PRS 74.61
-
CSI 2.11rCSI 2.47%PRS 88.37
-
CSI 2.1rCSI 4.01%PRS 85.3
-
CSI 2.1rCSI 10.35%PRS 83.36
-
CSI 2.1rCSI 50.2%PRS 54.1
-
CSI 2.1rCSI 50.56%PRS 54.7
-
CSI 2.09rCSI 4.34%PRS 71.05
-
CSI 2.07rCSI 1.82%PRS 62.43
-
CSI 2.06rCSI 3.01%PRS 78.86
-
CSI 2rCSI 1.93%PRS 73.38
-
CSI 1.97rCSI 3.53%PRS 73.29
-
CSI 1.97rCSI 3.14%PRS 65.61
-
CSI 1.96rCSI 7.92%PRS 73.39
-
CSI 1.96rCSI 1.69%PRS 78.53
-
CSI 1.95rCSI 1.7%PRS 84.14
-
CSI 1.94rCSI 3.09%PRS 66.6
-
CSI 1.93rCSI 1.52%PRS 80.19
-
CSI 1.92rCSI 1.74%PRS 86.84
-
CSI 1.91rCSI 1.85%PRS 66.26
-
CSI 1.9rCSI 1.75%PRS 75.72
-
CSI 1.87rCSI 5.53%PRS 75.6
-
CSI 1.8rCSI 2.09%PRS 79.23
-
CSI 1.8rCSI 2.31%PRS 56.7
-
CSI 1.79rCSI 2.76%PRS 73.07
-
CSI 1.77rCSI 4.49%PRS 63.91
-
CSI 1.76rCSI 6.61%PRS 66.05
-
CSI 1.75rCSI 2.02%PRS 66.22
-
CSI 1.74rCSI 2.49%PRS 75.45
-
CSI 1.72rCSI 3.24%PRS 83.18
-
CSI 1.7rCSI 3.18%PRS 61.84
-
CSI 1.64rCSI 2.11%PRS 77.66
-
CSI 1.64rCSI 2.88%PRS 70.1
-
CSI 1.64rCSI 1.26%PRS 76.36
-
CSI 1.63rCSI 2.85%PRS 66.82
-
CSI 1.61rCSI 2.14%PRS 80.07
-
CSI 1.58rCSI 1.89%PRS 89.96
-
CSI 1.57rCSI 1.96%PRS 83.84
-
CSI 1.57rCSI 1.95%PRS 75.33
-
CSI 1.51rCSI 1.87%PRS 71.47
-
CSI 1.45rCSI 1.81%PRS 53.4
-
CSI 1.4rCSI 1.8%PRS 70.31
-
CSI 1.39rCSI 3.38%PRS 53.58
-
CSI 1.35rCSI 2.69%PRS 70.18
-
CSI 1.34rCSI 1.21%PRS 71.65
-
CSI 1.31rCSI 1.56%PRS 55.32
-
CSI 1.23rCSI 3.05%PRS 73.12
-
CSI 1.12rCSI 1.88%PRS 55.38
-
CSI 1.06rCSI 1.88%PRS 44.43
-
CSI 1.02rCSI 8.82%PRS 61.06
-
CSI 1.02rCSI 5.78%PRS 59.47
-
CSI 0.99rCSI 2.19%PRS 59.69
-
CSI 0.92rCSI 1.12%PRS 56.37
-
CSI 0.91rCSI 7.44%PRS 67.67
-
CSI 0.91rCSI 2.65%PRS 63.16
-
CSI 0.86rCSI 1.25%PRS 87.65
-
CSI 0.86rCSI 2.68%PRS 59.66
-
CSI 0.83rCSI 1.01%PRS 82.46
-
CSI 0.82rCSI 3.62%PRS 62.65
-
CSI 0.81rCSI 4.05%PRS 86.18
-
CSI 0.6rCSI 2.1%PRS 55.9%
-
CSI 0.6rCSI 0.8%PRS 75.0%
-
CSI 0.6rCSI 3.5%PRS 56.4%
-
CSI 0.7rCSI 2.2%PRS 57.2%
-
CSI 0.8rCSI 5.5%PRS 60.8%
-
CSI 0.8rCSI 1.4%PRS 54.5%
-
CSI 0.8rCSI 1.2%PRS 79.3%
-
CSI 0.8rCSI 4.1%PRS 86.2%
-
CSI 0.8rCSI 3.6%PRS 62.7%
-
CSI 0.8rCSI 1.0%PRS 82.5%
-
CSI 0.9rCSI 2.7%PRS 59.7%
-
CSI 0.9rCSI 1.3%PRS 87.7%
-
CSI 0.9rCSI 2.7%PRS 63.2%
-
CSI 0.9rCSI 7.4%PRS 67.7%
-
CSI 0.9rCSI 1.1%PRS 56.4%
-
CSI 1.0rCSI 2.2%PRS 59.7%
-
CSI 1.0rCSI 5.8%PRS 59.5%
-
CSI 1.0rCSI 8.8%PRS 61.1%
-
CSI 1.1rCSI 1.9%PRS 44.4%
-
CSI 1.1rCSI 1.9%PRS 55.4%
-
CSI 1.2rCSI 3.1%PRS 73.1%
-
CSI 1.3rCSI 1.6%PRS 55.3%
-
CSI 1.3rCSI 1.2%PRS 71.7%
-
CSI 1.4rCSI 2.7%PRS 70.2%
-
CSI 1.4rCSI 3.4%PRS 53.6%
-
CSI 1.4rCSI 1.8%PRS 70.3%
-
CSI 1.5rCSI 1.8%PRS 53.4%
-
CSI 1.5rCSI 1.9%PRS 71.5%
-
CSI 1.6rCSI 2.0%PRS 75.3%
-
CSI 1.6rCSI 2.0%PRS 83.8%
-
CSI 1.6rCSI 1.9%PRS 90.0%
-
CSI 1.6rCSI 2.1%PRS 80.1%
-
CSI 1.6rCSI 2.9%PRS 66.8%
-
CSI 1.6rCSI 1.3%PRS 76.4%
-
CSI 1.6rCSI 2.9%PRS 70.1%
-
CSI 1.6rCSI 2.1%PRS 77.7%
-
CSI 1.7rCSI 3.2%PRS 61.8%
-
CSI 1.7rCSI 3.2%PRS 83.2%
-
CSI 1.7rCSI 2.5%PRS 75.5%
-
CSI 1.8rCSI 2.0%PRS 66.2%
-
CSI 1.8rCSI 6.6%PRS 66.1%
-
CSI 1.8rCSI 4.5%PRS 63.9%
-
CSI 1.8rCSI 2.8%PRS 73.1%
-
CSI 1.8rCSI 2.3%PRS 56.7%
-
CSI 1.8rCSI 2.1%PRS 79.2%
-
CSI 1.9rCSI 5.5%PRS 75.6%
-
CSI 1.9rCSI 1.8%PRS 75.7%
-
CSI 1.9rCSI 1.9%PRS 66.3%
-
CSI 1.9rCSI 1.7%PRS 86.8%
-
CSI 1.9rCSI 1.5%PRS 80.2%
-
CSI 1.9rCSI 3.1%PRS 66.6%
-
CSI 2.0rCSI 1.7%PRS 84.1%
-
CSI 2.0rCSI 1.7%PRS 78.5%
-
CSI 2.0rCSI 7.9%PRS 73.4%
-
CSI 2.0rCSI 3.1%PRS 65.6%
-
CSI 2.0rCSI 3.5%PRS 73.3%
-
CSI 2.0rCSI 1.9%PRS 73.4%
-
CSI 2.1rCSI 3.0%PRS 78.9%
-
CSI 2.1rCSI 1.8%PRS 62.4%
-
CSI 2.1rCSI 4.3%PRS 71.1%
-
CSI 2.1rCSI 50.6%PRS 54.7%
-
CSI 2.1rCSI 50.2%PRS 54.1%
-
CSI 2.1rCSI 10.4%PRS 83.4%
-
CSI 2.1rCSI 4.0%PRS 85.3%
-
CSI 2.1rCSI 2.5%PRS 88.4%
-
CSI 2.1rCSI 2.3%PRS 74.6%
-
CSI 2.1rCSI 3.1%PRS 66.8%
-
CSI 2.2rCSI 2.0%PRS 74.7%
-
CSI 2.2rCSI 3.1%PRS 70.3%
-
CSI 2.2rCSI 3.8%PRS 64.8%
-
CSI 2.3rCSI 5.2%PRS 62.0%
-
CSI 2.3rCSI 8.2%PRS 53.5%
-
CSI 2.3rCSI 4.6%PRS 63.5%
-
CSI 2.3rCSI 3.0%PRS 85.8%
-
CSI 2.4rCSI 3.8%PRS 57.1%
-
CSI 2.4rCSI 4.0%PRS 63.2%
-
CSI 2.5rCSI 1.7%PRS 77.3%
-
CSI 2.5rCSI 2.6%PRS 77.3%
-
CSI 2.6rCSI 3.7%PRS 63.5%
-
CSI 2.6rCSI 1.6%PRS 89.7%
-
CSI 2.7rCSI 4.9%PRS 64.9%
-
CSI 2.9rCSI 2.0%PRS 88.3%
-
CSI 2.9rCSI 2.3%PRS 61.6%
-
CSI 3.0rCSI 3.5%PRS 65.5%
-
CSI 3.0rCSI 2.5%PRS 76.5%
-
CSI 3.1rCSI 2.3%PRS 80.0%
-
CSI 3.1rCSI 2.3%PRS 67.0%
-
CSI 3.1rCSI 3.1%PRS 88.1%
-
CSI 3.1rCSI 3.8%PRS 72.1%
-
CSI 3.2rCSI 7.2%PRS 65.2%
-
CSI 3.2rCSI 6.5%PRS 52.2%
-
CSI 3.4rCSI 11.3%PRS 58.1%
-
CSI 3.4rCSI 21.4%PRS 65.5%
-
CSI 3.5rCSI 5.8%PRS 78.9%
-
CSI 3.6rCSI 7.9%PRS 81.8%
-
CSI 3.6rCSI 8.1%PRS 56.0%
-
CSI 3.7rCSI 9.5%PRS 74.5%
-
CSI 3.7rCSI 5.0%PRS 83.7%
-
CSI 3.8rCSI 2.6%PRS 87.2%
-
CSI 3.9rCSI 6.2%PRS 63.6%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3846004637
Symbol: CUL2_HUMAN
Name: Cullin-2
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 9122164
Title: The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
PubMed ID: 9122164
PubMed ID: 10092517
Title: Identification of NEDD8-conjugation site in human cullin-2.
PubMed ID: 10092517
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15164054
Title: The DNA sequence and comparative analysis of human chromosome 10.
PubMed ID: 15164054
DOI: 10.1038/nature02462
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 8681378
Title: cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family.
PubMed ID: 8681378
PubMed ID: 10230407
Title: ROC1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity.
PubMed ID: 10230407
PubMed ID: 10973499
Title: Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex.
PubMed ID: 10973499
PubMed ID: 11384984
Title: Muf1, a novel elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.
PubMed ID: 11384984
PubMed ID: 12149480
Title: Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.
PubMed ID: 12149480
PubMed ID: 12609982
Title: TIP120A associates with cullins and modulates ubiquitin ligase activity.
PubMed ID: 12609982
PubMed ID: 10597293
Title: Covalent modification of all members of human cullin family proteins by NEDD8.
PubMed ID: 10597293
PubMed ID: 15601820
Title: VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases.
PubMed ID: 15601820
DOI: 10.1101/gad.1252404
PubMed ID: 17304241
Title: The Caenorhabditis elegans cell-cycle regulator ZYG-11 defines a conserved family of CUL-2 complex components.
PubMed ID: 17304241
PubMed ID: 17251292
Title: Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.
PubMed ID: 17251292
DOI: 10.1128/jvi.02303-06
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23102700
Title: The Kelch repeat protein KLHDC10 regulates oxidative stress-induced ASK1 activation by suppressing PP5.
PubMed ID: 23102700
PubMed ID: 22286099
Title: The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity.
PubMed ID: 22286099
DOI: 10.1038/ncb2424
PubMed ID: 24076655
Title: TRIAD1 and HHARI bind to and are activated by distinct neddylated Cullin-RING ligase complexes.
PubMed ID: 24076655
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
PubMed ID: 23401859
Title: DCNL1 functions as a substrate sensor and activator of cullin 2-RING ligase.
PubMed ID: 23401859
DOI: 10.1128/mcb.01342-12
PubMed ID: 23201271
Title: Structural conservation of distinctive N-terminal acetylation-dependent interactions across a family of mammalian NEDD8 ligation enzymes.
PubMed ID: 23201271
PubMed ID: 24192928
Title: Oncogenic function of SCCRO5/DCUN1D5 requires its Neddylation E3 activity and nuclear localization.
PubMed ID: 24192928
PubMed ID: 27565346
Title: Two distinct types of E3 ligases work in unison to regulate substrate ubiquitylation.
PubMed ID: 27565346
PubMed ID: 26906416
Title: Characterization of the mammalian family of DCN-type NEDD8 E3 ligases.
PubMed ID: 26906416
DOI: 10.1242/jcs.181784
PubMed ID: 26138980
Title: SELENOPROTEINS. CRL2 aids elimination of truncated selenoproteins produced by failed UGA/Sec decoding.
PubMed ID: 26138980
PubMed ID: 29779948
Title: The eukaryotic proteome is shaped by E3 ubiquitin ligases targeting C-terminal degrons.
PubMed ID: 29779948
PubMed ID: 29775578
Title: C-terminal end-directed protein elimination by CRL2 ubiquitin ligases.
PubMed ID: 29775578
PubMed ID: 34700328
Title: A conserved mechanism for regulating replisome disassembly in eukaryotes.
PubMed ID: 34700328
Sequence Information:
- Length: 745
- Mass: 86983
- Checksum: 30647248F671AB0E
- Sequence:
MSLKPRVVDF DETWNKLLTT IKAVVMLEYV ERATWNDRFS DIYALCVAYP EPLGERLYTE TKIFLENHVR HLHKRVLESE EQVLVMYHRY WEEYSKGADY MDCLYRYLNT QFIKKNKLTE ADLQYGYGGV DMNEPLMEIG ELALDMWRKL MVEPLQAILI RMLLREIKND RGGEDPNQKV IHGVINSFVH VEQYKKKFPL KFYQEIFESP FLTETGEYYK QEASNLLQES NCSQYMEKVL GRLKDEEIRC RKYLHPSSYT KVIHECQQRM VADHLQFLHA ECHNIIRQEK KNDMANMYVL LRAVSTGLPH MIQELQNHIH DEGLRATSNL TQENMPTLFV ESVLEVHGKF VQLINTVLNG DQHFMSALDK ALTSVVNYRE PKSVCKAPEL LAKYCDNLLK KSAKGMTENE VEDRLTSFIT VFKYIDDKDV FQKFYARMLA KRLIHGLSMS MDSEEAMINK LKQACGYEFT SKLHRMYTDM SVSADLNNKF NNFIKNQDTV IDLGISFQIY VLQAGAWPLT QAPSSTFAIP QELEKSVQMF ELFYSQHFSG RKLTWLHYLC TGEVKMNYLG KPYVAMVTTY QMAVLLAFNN SETVSYKELQ DSTQMNEKEL TKTIKSLLDV KMINHDSEKE DIDAESSFSL NMNFSSKRTK FKITTSMQKD TPQEMEQTRS AVDEDRKMYL QAAIVRIMKA RKVLRHNALI QEVISQSRAR FNPSISMIKK CIEVLIDKQY IERSQASADE YSYVA
Genular Protein ID: 1649295460
Symbol: A0A8I5KVR3_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 15164054
Title: The DNA sequence and comparative analysis of human chromosome 10.
PubMed ID: 15164054
DOI: 10.1038/nature02462
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
Sequence Information:
- Length: 682
- Mass: 79518
- Checksum: CB4CD9BFECFDA251
- Sequence:
MSLKPRVVDF DETWNKLLTT IKAVVMLEYV ERATWNDRFS DIYALCVAYP EPLGERLYTE TKIFLENHVR HLHKRVLESE EQVLVMYHRY WEEYSKGADY MDCLYSDRGG EDPNQKVIHG VINSFVHVEQ YKKKFPLKFY QEIFESPFLT ETGEYYKQEA SNLLQESNCS QYMEKVLGRL KDEEIRCRKY LHPSSYTKVI HECQQRMVAD HLQFLHAECH NIIRQEKKND MANMYVLLRA VSTGLPHMIQ ELQNHIHDEG LRATSNLTQE NMPTLFVESV LEVHGKFVQL INTVLNGDQH FMSALDKALT SVVNYREPKS VCKAPELLAK YCDNLLKKSA KGMTENEVED RLTSFITVFK YIDDKDVFQK FYARMLAKRL IHGLSMSMDS EEAMINKLKQ ACGYEFTSKL HRMYTDMSVS ADLNNKFNNF IKNQDTVIDL GISFQIYVLQ AGAWPLTQAP SSTFAIPQEL EKSVQMFELF YSQHFSGRKL TWLHYLCTGE VKMNYLGKPY VAMVTTYQMA VLLAFNNSET VSYKELQDST QMNEKELTKT IKSLLDVKMI NHDSEKEDID AESSFSLNMN FSSKRTKFKI TTSMQKDTPQ EMEQTRSAVD EDRKMYLQAA IVRIMKARKV LRHNALIQEV ISQSRARFNP SISMIKKCIE VLIDKQYIER SQASADEYSY VA
Genular Protein ID: 609978033
Symbol: B7Z1Y1_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Sequence Information:
- Length: 582
- Mass: 67866
- Checksum: 585E4C2EC4F5EE4D
- Sequence:
MSLKPRVVDF DETWNKLLTT IKAVVMLEYV ERATWNDRFS DIYALCVAYP EPLGERLYTE TKIFLENHVR HLHKRVLESE EQVLVMYHRY WEEYSKGADY MDCLYSDRGG EDPNQKVIHG VINSFVHVEQ YKKKFPLKFY QEIFESPFLT ETGEYYKQEA SNLLQESNCS QYMEKVLGRL KDEEIRCRKY LHPSSYTKVI HECQQRMVAD HLQFLHAECH NIIRQEKKND MANMYVLLRA VSTGLPHMIQ ELQNHIHDEG LRATSNLTQE NMPTLFVESV LEVHGKFVQL INTVLNGDQH FMSALDKALT SVVNYREPKS VCKAPELLAK YCDNLLKKSA KGMTENEVED RLTSFITVFK YIDDKDVFQK FYARMLAKRL IHGLSMSMDS EEAMINKLKQ ACGYEFTSKL HRMYTDMSVS ADLNNKFNNF IKNQDTVIDL GISFQIYVLQ AGAWPLTQAP SSTFAIPQEL EKSVQMFELF YSQHFSGRKL TWLHYLCTGE VKMNYLGKPY VAMVTTYQMA VLLAFNNSET VSYKELQDST QMNEKELTKT IKSLLDVKMI NHDSEKEDID AESSFSLNMN FS
Genular Protein ID: 4190002926
Symbol: A0A0A0MTN0_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 15164054
Title: The DNA sequence and comparative analysis of human chromosome 10.
PubMed ID: 15164054
DOI: 10.1038/nature02462
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19608861
Title: Lysine acetylation targets protein complexes and co-regulates major cellular functions.
PubMed ID: 19608861
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
Sequence Information:
- Length: 758
- Mass: 88506
- Checksum: 126BC92627C9420A
- Sequence:
MVPGKEFQHY TCTMSLKPRV VDFDETWNKL LTTIKAVVML EYVERATWND RFSDIYALCV AYPEPLGERL YTETKIFLEN HVRHLHKRVL ESEEQVLVMY HRYWEEYSKG ADYMDCLYRY LNTQFIKKNK LTEADLQYGY GGVDMNEPLM EIGELALDMW RKLMVEPLQA ILIRMLLREI KNDRGGEDPN QKVIHGVINS FVHVEQYKKK FPLKFYQEIF ESPFLTETGE YYKQEASNLL QESNCSQYME KVLGRLKDEE IRCRKYLHPS SYTKVIHECQ QRMVADHLQF LHAECHNIIR QEKKNDMANM YVLLRAVSTG LPHMIQELQN HIHDEGLRAT SNLTQENMPT LFVESVLEVH GKFVQLINTV LNGDQHFMSA LDKALTSVVN YREPKSVCKA PELLAKYCDN LLKKSAKGMT ENEVEDRLTS FITVFKYIDD KDVFQKFYAR MLAKRLIHGL SMSMDSEEAM INKLKQACGY EFTSKLHRMY TDMSVSADLN NKFNNFIKNQ DTVIDLGISF QIYVLQAGAW PLTQAPSSTF AIPQELEKSV QMFELFYSQH FSGRKLTWLH YLCTGEVKMN YLGKPYVAMV TTYQMAVLLA FNNSETVSYK ELQDSTQMNE KELTKTIKSL LDVKMINHDS EKEDIDAESS FSLNMNFSSK RTKFKITTSM QKDTPQEMEQ TRSAVDEDRK MYLQAAIVRI MKARKVLRHN ALIQEVISQS RARFNPSISM IKKCIEVLID KQYIERSQAS ADEYSYVA